GB202011871D0 - Composition and method - Google Patents

Composition and method

Info

Publication number
GB202011871D0
GB202011871D0 GBGB2011871.7A GB202011871A GB202011871D0 GB 202011871 D0 GB202011871 D0 GB 202011871D0 GB 202011871 A GB202011871 A GB 202011871A GB 202011871 D0 GB202011871 D0 GB 202011871D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2011871.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Priority to GBGB2011871.7A priority Critical patent/GB202011871D0/en
Publication of GB202011871D0 publication Critical patent/GB202011871D0/en
Priority to EP21756024.2A priority patent/EP4188940A1/en
Priority to US18/007,378 priority patent/US20230295237A1/en
Priority to JP2023505948A priority patent/JP7841821B2/ja
Priority to AU2021319154A priority patent/AU2021319154A1/en
Priority to BR112023001611A priority patent/BR112023001611A2/pt
Priority to PCT/GB2021/051985 priority patent/WO2022023773A1/en
Priority to CN202180066253.7A priority patent/CN116406427A/zh
Priority to CA3190289A priority patent/CA3190289A1/en
Priority to KR1020237007325A priority patent/KR20230041820A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14145—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14171—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Epidemiology (AREA)
GBGB2011871.7A 2020-07-30 2020-07-30 Composition and method Ceased GB202011871D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB2011871.7A GB202011871D0 (en) 2020-07-30 2020-07-30 Composition and method
KR1020237007325A KR20230041820A (ko) 2020-07-30 2021-07-30 조성물 및 방법
AU2021319154A AU2021319154A1 (en) 2020-07-30 2021-07-30 Composition and method
US18/007,378 US20230295237A1 (en) 2020-07-30 2021-07-30 Composition and method
JP2023505948A JP7841821B2 (ja) 2020-07-30 2021-07-30 組成物および方法
EP21756024.2A EP4188940A1 (en) 2020-07-30 2021-07-30 Composition and method
BR112023001611A BR112023001611A2 (pt) 2020-07-30 2021-07-30 Proteína do capsídeo de vírus adenoassociado (aav), ácido nucleico, dna recombinante, célula hospedeira, partícula viral, animal transgênico, composição farmacêutica, proteína do capsídeo e método de direcionamento para a microglia ou macrófagos cerebrais
PCT/GB2021/051985 WO2022023773A1 (en) 2020-07-30 2021-07-30 Composition and method
CN202180066253.7A CN116406427A (zh) 2020-07-30 2021-07-30 组合物和方法
CA3190289A CA3190289A1 (en) 2020-07-30 2021-07-30 Composition and method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2011871.7A GB202011871D0 (en) 2020-07-30 2020-07-30 Composition and method

Publications (1)

Publication Number Publication Date
GB202011871D0 true GB202011871D0 (en) 2020-09-16

Family

ID=72425275

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2011871.7A Ceased GB202011871D0 (en) 2020-07-30 2020-07-30 Composition and method

Country Status (10)

Country Link
US (1) US20230295237A1 (cg-RX-API-DMAC7.html)
EP (1) EP4188940A1 (cg-RX-API-DMAC7.html)
JP (1) JP7841821B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230041820A (cg-RX-API-DMAC7.html)
CN (1) CN116406427A (cg-RX-API-DMAC7.html)
AU (1) AU2021319154A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023001611A2 (cg-RX-API-DMAC7.html)
CA (1) CA3190289A1 (cg-RX-API-DMAC7.html)
GB (1) GB202011871D0 (cg-RX-API-DMAC7.html)
WO (1) WO2022023773A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202022003132U1 (de) 2021-04-01 2025-02-17 The Regents Of The University Of California Genetische Modifikation von Säugerzellen zur Verleihung von Resistenz gegen CSF1R-Antagonisten
CN119095867A (zh) * 2022-03-24 2024-12-06 卡西达公司 具有优选的脑富集的所选aav组合物
CA3254570A1 (en) * 2022-03-24 2023-09-28 Capsida, Inc. ADENE-ASSOCIATED VIRUS COMPOSITIONS WITH INCREASED CARDIAC ENRICHEMENT
AU2023267474A1 (en) * 2022-05-13 2024-12-05 Children's Medical Research Institute Adeno-associated virus capsids
EP4526325A4 (en) * 2022-05-17 2026-08-05 Capsida Inc SELECTED ADENE-ASSOCIATED VIRUS COMPOSITIONS HAVING PREFERRED LEVELS OF CEREBRAL, SPINAL CORD AND/OR CARDIAC EXPRESSION
US20260108560A1 (en) * 2022-07-13 2026-04-23 The Regents Of The University Of California Transplanting stem cell-derived microglia to treat leukodystrophies
KR20260003703A (ko) * 2023-04-07 2026-01-07 4디 몰레큘러 테라퓨틱스 아이엔씨. 보체 장애의 치료를 위한 aav 변이체
CN118480098B (zh) * 2023-09-20 2024-11-08 广州派真生物技术有限公司 腺相关病毒突变体及其应用
CN117660370B (zh) * 2023-11-08 2025-03-21 中国人民解放军空军军医大学 一种重组腺相关病毒、抗炎药物及其在脓毒性脑病治疗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3564379A1 (en) 2013-09-13 2019-11-06 California Institute of Technology Selective recovery
AU2016366549B2 (en) 2015-12-11 2022-11-10 California Institute Of Technology Targeting peptides for directing adeno-associated viruses (AAVs)
US11512327B2 (en) 2017-08-03 2022-11-29 Voyager Therapeutics, Inc. Compositions and methods for delivery of AAV
EP3830107A2 (en) * 2018-08-03 2021-06-09 Voyager Therapeutics, Inc. Aav variants with enhanced tropism

Also Published As

Publication number Publication date
CN116406427A (zh) 2023-07-07
US20230295237A1 (en) 2023-09-21
WO2022023773A1 (en) 2022-02-03
JP2023535620A (ja) 2023-08-18
BR112023001611A2 (pt) 2023-02-14
JP7841821B2 (ja) 2026-04-07
AU2021319154A1 (en) 2023-03-23
CA3190289A1 (en) 2022-02-03
KR20230041820A (ko) 2023-03-24
EP4188940A1 (en) 2023-06-07

Similar Documents

Publication Publication Date Title
GB202006792D0 (en) Method and uses thereof
GB2628740B (en) Wingsail and method
IL300332B2 (en) Composition and method
GB2614585B (en) Wingsail and method
GB2593010B (en) Composition and Method
GB202100998D0 (en) Composition and method
GB202100997D0 (en) Composition and method
GB202010449D0 (en) Method and composition
GB2579687B (en) Composition and method
GB202109827D0 (en) Method and composition
GB202102310D0 (en) Composition and method
GB202016644D0 (en) Composition and method
GB202217944D0 (en) Compositions and method
GB2603642B (en) Method and composition
GB201914777D0 (en) Composition and method
GB202113086D0 (en) Composition and method
GB202113085D0 (en) Composition and method
GB202108601D0 (en) Composition and method
GB202105673D0 (en) Method and composition
GB202018825D0 (en) Composition and method
GB202016617D0 (en) Composition and method
GB202016633D0 (en) Composition and method
GB202016620D0 (en) Composition and method
GB202016629D0 (en) Composition and method
GB202016645D0 (en) Composition and method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)